abstract |
The present invention relates to novel compounds that inhibit LRRK2 kinase activity, methods for their production, compositions containing them, and diseases associated with or characterized by LRRK2 kinase activity, such as Parkinson's disease. With respect to their use in the treatment or prevention of Alzheimer's disease and amyotrophic lateral sclerosis (ALS). |